A recent study from the University of Georgia has highlighted a potential link between opioid use and increased susceptibility to infections, particularly focusing on the Clostridioides difficile bacterium, commonly known as C. diff. This discovery could have significant implications for patients using opioids, particularly those with already weakened immune systems.
C. diff, a bacterium that primarily attacks the colon, can cause severe symptoms such as diarrhea, nausea, and vomiting. It affects approximately 500,000 individuals annually and can be fatal in severe cases. Research indicates that the use of opioids may heighten the risk of contracting this infection, adding to the known risk factors like antibiotic use and weakened immunity.
The study conducted a comprehensive meta-analysis of four separate studies, encompassing nearly 120,000 patients. Findings revealed that 31% of patients on opioid prescriptions contracted C. diff, in contrast to 17% among those not using opioids.
Pooja Gokhale, the lead author of the study and a doctoral candidate at UGA’s College of Pharmacy, explained, “Opioids mess with the gut microbiome, and that creates an environment that is more likely to support C. diff colonization. And because opioids can lead to immunosuppression, you’re more susceptible to infections in general, and of course, C. diff is a highly infectious disease.”
Despite these findings, opioids remain a crucial option for certain medical treatments. The researchers emphasize the importance of evaluating each patient’s unique situation when considering opioid prescriptions. Gokhale stated, “It has to be case by case. Each patient has a very different history. If it’s a healthy young patient, physicians may not be as concerned about the risk, but hospitalized or immunocompromised patients are already at high risk.”
The research has been published in the American Journal of Infection Control.
